Page last updated: 2024-10-31

nevirapine and Lupus Erythematosus, Systemic

nevirapine has been researched along with Lupus Erythematosus, Systemic in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck-Engeser, GB1
Eilat, D1
Wabl, M1

Other Studies

1 other study available for nevirapine and Lupus Erythematosus, Systemic

ArticleYear
An autoimmune disease prevented by anti-retroviral drugs.
    Retrovirology, 2011, Nov-08, Volume: 8

    Topics: Animals; Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Deoxycytidine; Drug Combina

2011